Finance

Lists
Why is 000756 up 2.16%?
Dive Deeper
000756:SHE
Shandong Xinhua Pharmaceutical Ord Shs A
CNÂ¥13.70
+2.16%
(+0.29) 1D
Oct 16, 3:04:48 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000756...
Open
CNÂ¥13.49
High
CNÂ¥14.27
Low
CNÂ¥13.48
Mkt. cap
7.79B
Avg. vol.
23.82M
Volume
34.17M
Dividend
1.09%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 10, 2026
P/E ratio
44.55
52-wk high
CNÂ¥18.70
52-wk low
CNÂ¥11.71
EPS
CNÂ¥0.31
Shares outstanding
501.68M
No. of employees
7K
Open
CNÂ¥13.49
High
CNÂ¥14.27
Low
CNÂ¥13.48
Mkt. cap
7.79B
Avg. vol.
23.82M
Volume
34.17M
Dividend
1.09%
Quarterly dividend
CNÂ¥0.04
Ex-dividend date
Jul 10, 2026
P/E ratio
44.55
52-wk high
CNÂ¥18.70
52-wk low
CNÂ¥11.71
EPS
CNÂ¥0.31
Shares outstanding
501.68M
No. of employees
7K
News stories
From web sources and news partners
About Shandong Xinhua Pharmaceutical Ord Shs A
CEO-
Employees7.02K
FoundedNov 1943
Headquarters-
SectorPharmaceutical industry
Websitexhzy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.12B
1.99B
2.42B
1.93B
Cost of goods sold
1.70B
1.70B
1.98B
1.58B
Cost of revenue
1.70B
1.70B
1.98B
1.58B
Research and development expenses
97.68M
81.51M
95.47M
97.22M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
211.30M
197.11M
198.38M
172.75M
Operating expense
297.65M
313.15M
307.72M
296.26M
Total operating expenses
2.00B
2.01B
2.29B
1.88B
Operating income
121.85M
-17.39M
133.38M
53.70M
Other non operating income
5.12M
-4.38M
-7.51M
6.21M
EBT including unusual items
42.47M
52.92M
118.63M
46.31M
EBT excluding unusual items
111.70M
-28.30M
118.92M
44.81M
Income tax expense
6.73M
13.52M
35.37M
-18.38M
Effective tax rate
15.84%
25.56%
29.81%
-39.68%
Other operating expenses
-12.15M
37.37M
13.91M
20.13M
Net income
32.46M
33.67M
83.90M
65.22M
Net profit margin
1.53%
1.69%
3.46%
3.37%
Earnings per share
0.03
0.04
0.12
0.10
Interest and investment income
103.84K
4.92M
1.17M
8.82M
Interest expense
-7.31M
-13.67M
-8.45M
-8.81M
Net interest expenses
-7.21M
-8.75M
-7.28M
4.06K
Depreciation and amortization charges
-
-
-
-
EBITDA
256.56M
129.14M
279.91M
205.42M
Gain or loss from assets sale
1.71M
-1.99M
-
-93.38K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps